Fetal stem cell therapy shows promise for treating spina bifida

gizmodo.com

In-utero stem cell therapy for spina bifida showed promising safety in a Phase I trial. The treatment, combined with prenatal surgery, appeared to have no adverse events in newborns and may have enhanced surgical effectiveness. This research, published in The Lancet, offers potential for future fetal cell and gene therapies for birth defects.


With a significance score of 5.1, this news ranks in the top 1.1% of today's 29305 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Fetal stem cell therapy shows promise for treating spina bifida | News Minimalist